Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-02

Clinical Trial Update: Glycemic Response to Six Meal Replacements in Persons With Type 2 Diabetes Mellitus [NA]

View source ↗

Summary

A completed clinical trial evaluated the glycemic response to six meal replacement products in adults with Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Société des Produits Nestlé (SPN) | Conditions: Diabetes | NA | Status: COMPLETED